Albany, NY -- (SBWIRE) -- 08/04/2017 -- The behavior of drugs with regard to solubility has been one of the most crucial aspects of developing a formulation. Drug formulations are adversely affected by poor solubility and low permeability. Approximately 40% of the modern drugs that are marketed is classified by the Biopharmaceutical Classification System (BCS) into two subcategories of the low-solubility drugs. Additionally, a study on drug entities in development revealed that the percentage would increase to 80%. This inclination of the pharmaceutical industry toward low-solubility drugs will lead to the requirement of solubility enhancement excipients to increase the solubility of these drugs in the physiological system. Therefore, the rise in the production of low-solubility drug ingredients is directly proportional to the rise in the production of polymer-based solubility enhancement excipients for oral solid dosage forms (OSDF). Therefore, the success of a medication in the pharmaceutical industry depends principally on the function carried on by solubility enhancement excipients.
The global polymer based solubility enhancement excipients market for OSDF to grow at a CAGR of 16.56% during the period 2017-2021. The report covers the present scenario and the growth prospects of the global polymer based solubility enhancement excipients market for OSDF for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of polymer based solubility enhancement excipients for OSDF.
Click to get sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1064764
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Technavio's report, Global Polymer Based Solubility Enhancement Excipients Market for OSDF 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Browse more details at: http://www.researchmoz.us/global-polymer-based-solubility-enhancement-excipients-market-for-osdf-2017-2021-report.html
Key vendors
- Ashland
- BASF
- Dow Chemical
- Evonik
- Shin-Etsu Chemical
Other prominent vendors
- Clariant
- Freund
- Maple Biotech
- Nisso America
- Peter Cremer
- SPI Pharma
- The Lubrizol Corporation
Market driver
- Increase in production of low-solubility drugs
- For a full, detailed list, view our report
Market challenge
- Lack of adequate information
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG